Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,422 | 200 | 97.2% |
| Education | $99.95 | 1 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $575.03 | 41 | $0 (2024) |
| ABBVIE INC. | $284.94 | 15 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $278.67 | 18 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $258.88 | 18 | $0 (2019) |
| Lilly USA, LLC | $254.40 | 13 | $0 (2024) |
| PFIZER INC. | $204.21 | 13 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $198.76 | 13 | $0 (2024) |
| Amgen Inc. | $159.46 | 3 | $0 (2024) |
| Astellas Pharma US Inc | $148.77 | 4 | $0 (2023) |
| Exact Sciences Corporation | $146.59 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $833.70 | 43 | Novo Nordisk Inc ($169.92) |
| 2023 | $653.97 | 35 | Novo Nordisk Inc ($140.41) |
| 2022 | $541.10 | 30 | Boehringer Ingelheim Pharmaceuticals, Inc. ($75.85) |
| 2021 | $498.22 | 28 | AbbVie Inc. ($128.89) |
| 2020 | $86.17 | 5 | Sunovion Pharmaceuticals Inc. ($42.57) |
| 2019 | $291.93 | 15 | Astellas Pharma US Inc ($99.95) |
| 2018 | $331.90 | 23 | Janssen Pharmaceuticals, Inc ($162.14) |
| 2017 | $284.87 | 22 | Novo Nordisk Inc ($104.96) |
All Payment Transactions
201 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.71 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $1.66 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Gastroenterology | ||||||
| 10/16/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Diabetes | ||||||
| 10/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.85 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Oncology | ||||||
| 09/11/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Diabetes | ||||||
| 08/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Respiratory | ||||||
| 08/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.43 | General |
| Category: Diabetes | ||||||
| 07/18/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Respiratory | ||||||
| 07/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Diabetes | ||||||
| 07/11/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: WATCHMAN_IC | ||||||
| 07/01/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Respiratory | ||||||
| 06/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.27 | General |
| Category: Diabetes | ||||||
| 06/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Respiratory | ||||||
| 06/24/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Diabetes | ||||||
| 06/12/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: Hematology | ||||||
| 06/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Diabetes | ||||||
| 06/05/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 762 | 1,327 | $230,424 | $109,975 |
| 2022 | 11 | 1,014 | 1,767 | $281,458 | $137,248 |
| 2021 | 16 | 1,245 | 1,976 | $315,671 | $160,253 |
| 2020 | 13 | 1,292 | 2,090 | $351,205 | $161,939 |
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 170 | 460 | $69,000 | $27,315 | 39.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 140 | 286 | $62,920 | $26,173 | 41.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 117 | 117 | $28,010 | $14,775 | 52.7% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 85 | 91 | $21,658 | $13,061 | 60.3% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 51 | 148 | $20,627 | $11,783 | 57.1% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 30 | 36 | $8,545 | $5,003 | 58.5% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 77 | 82 | $8,087 | $4,877 | 60.3% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 12 | 22 | $3,066 | $1,849 | 60.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 23 | 26 | $2,807 | $1,666 | 59.3% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 14 | 14 | $2,439 | $1,447 | 59.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 11 | 11 | $1,100 | $833.91 | 75.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 13 | 15 | $1,500 | $610.35 | 40.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 19 | 19 | $665.00 | $581.97 | 87.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 183 | 613 | $91,950 | $38,607 | 42.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 117 | 248 | $54,560 | $23,107 | 42.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 113 | 113 | $27,120 | $14,789 | 54.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 123 | 177 | $19,771 | $12,033 | 60.9% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Office | 2022 | 84 | 93 | $20,097 | $11,891 | 59.2% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 62 | 130 | $15,420 | $8,896 | 57.7% |
| 99358 | Extended patient service without direct patient contact, first hour | Office | 2022 | 86 | 95 | $13,773 | $8,177 | 59.4% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 43 | 50 | $10,800 | $6,596 | 61.1% |
| 99358 | Extended patient service without direct patient contact, first hour | Facility | 2022 | 42 | 49 | $7,103 | $4,344 | 61.2% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2022 | 42 | 56 | $5,710 | $3,487 | 61.1% |
| 99318 | Nursing facility annual assessment, typically 30 minutes | Office | 2022 | 29 | 29 | $3,609 | $2,192 | 60.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 37 | 61 | $9,394 | $1,893 | 20.2% |
About Dr. Ronald Luna, MD
Dr. Ronald Luna, MD is a Internal Medicine healthcare provider based in Seaford, Delaware. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/20/2012. The National Provider Identifier (NPI) number assigned to this provider is 1285982447.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ronald Luna, MD has received a total of $3,522 in payments from pharmaceutical and medical device companies, with $833.70 received in 2024. These payments were reported across 201 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($3,422).
As a Medicare-enrolled provider, Luna has provided services to 4,313 Medicare beneficiaries, totaling 7,160 services with total Medicare billing of $569,415. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Seaford, DE
- Active Since 08/20/2012
- Last Updated 03/07/2017
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1285982447
Products in Payments
- XARELTO (Drug) $229.69
- Ozempic (Drug) $195.94
- Rybelsus (Drug) $194.81
- BREZTRI (Drug) $179.45
- UBRELVY (Drug) $165.69
- Cologuard Collection Kit (Device) $146.59
- Repatha (Biological) $143.72
- MOUNJARO (Drug) $142.17
- PREMARIN (Drug) $128.08
- ENTRESTO (Drug) $127.18
- JARDIANCE (Drug) $122.60
- Dexcom G6 Transmitter (Medical Supply) $87.11
- Tresiba (Drug) $74.54
- REXULTI (Drug) $73.23
- FARXIGA (Drug) $70.18
- APTIOM (Drug) $66.28
- VRAYLAR (Drug) $66.18
- STIOLTO RESPIMAT (Drug) $61.23
- Kerendia (Drug) $56.20
- TRADJENTA (Drug) $54.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Seaford
Dr. Jeffrey Elfenbein, D.o, D.O
Internal Medicine — Payments: $27,890
Dr. Mark Evangelista, M.d, M.D
Internal Medicine — Payments: $13,519
Dr. Richard Simons, D.o, D.O
Internal Medicine — Payments: $7,910
Dr. Angel Alicea, M.d, M.D
Internal Medicine — Payments: $7,728
Dr. Louis Crevecoeur, Md, MD
Internal Medicine — Payments: $5,826
Alvaro Buenano, M.d, M.D
Internal Medicine — Payments: $5,198